TrialInternational journal of clinical oncology2025

Concurrent chemoradiotherapy with weekly low-dose carboplatin for cisplatin-ineligible patients with head and neck squamous cell carcinoma: survival analysis based on 2-year follow-up data.

Yushi Ueki et al.PubMed ↗Publisher ↗

No numbers read from the abstract.